China Pharma Holdings (CPHI) Land & Improvements (2014 - 2023)
China Pharma Holdings' Land & Improvements was $389,808 in Q2 2023, down 7.1% from $419,685 a year earlier and down 4.9% from the prior quarter.
Powered by 
Analysis
China Pharma Holdings (CPHI) Land & Improvements (2014 - 2023) Analysis & Trends
At the end of FY2022, Land & Improvements at China Pharma Holdings came in at $404,427, down 8.5% from FY2021.
- Land & Improvements shows a five-year compound annual growth rate of -1.4% (FY2017 to FY2022).
- In earlier years, Land & Improvements was $441,783 in FY2021 (+2.3%), $431,681 in FY2020 (+6.9%), $403,755 in FY2019 (-1.4%) and $409,612 in FY2018 (-5.4%).
- The Q2 2023 figure marks the lowest quarterly Land & Improvements in data going back to Q4 2014.
- Compared with a year earlier, Land & Improvements has declined for five straight quarters, with an average decline of 4.0% over the last seven quarters.
- The best year-over-year quarter for Land & Improvements over five years was Q2 2021 (growth of 9.6%); the worst was Q3 2022 (a decline of 8.7%).
- Per Business Quant data, CPHI's Land & Improvements in the three quarters before Q2 2023 was $409,895 (Q1 2023), $404,427 (Q4 2022) and $396,726 (Q3 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | China Pharma Holdings | 28.40 Mn | 27.28 Mn | 83,566.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 389,808.00 |
| Mar 31, 2023 | 409,895.00 |
| Dec 31, 2022 | 404,427.00 |
| Sep 30, 2022 | 396,726.00 |
| Jun 30, 2022 | 419,685.00 |
| Mar 31, 2022 | 443,697.00 |
| Dec 31, 2021 | 441,783.00 |
| Sep 30, 2021 | 434,310.00 |
| Jun 30, 2021 | 436,011.00 |
| Dec 31, 2020 | 431,681.00 |
| Sep 30, 2020 | 413,603.00 |
| Jun 30, 2020 | 397,864.00 |
| Mar 31, 2020 | 428,633.00 |
| Dec 31, 2019 | 403,755.00 |
| Sep 30, 2019 | 398,235.00 |
| Jun 30, 2019 | 409,716.00 |
| Mar 31, 2019 | 419,703.00 |
| Dec 31, 2018 | 409,612.00 |
| Sep 30, 2018 | 410,203.00 |
| Jun 30, 2018 | 425,541.00 |
API Access
China Pharma Holdings Land & Improvements API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=land-and-improvements&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "land-and-improvements", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=land-and-improvements&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();